Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28‐Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score‐II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index‐5 (RADAI‐5), Chronic Arthritis Systemic Index (CASI), Patient‐Based Disease Activity Score With ESR (PDAS1) and Patient‐Based Disease Activity Score Without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI‐RA)

Cited by (260)

Items 201–260 of 260

  1. The Hindi Version of McGill Pain Questionnaire: A Cross-Cultural Adaptation Study in Rheumatoid Arthritis
    Riddhi Ashish Shroff, Twinkle Dabholkar · 2021 · Indian Journal of Rheumatology
  2. Correlation of Disease Activity Scores and Routine Assessment of Patient Index Data (RAPID3) on a Multidimensional Health Assessment Questionnaire in Patients With Rheumatoid Arthritis: A Saudi Experience
    Sultana Abdulaziz, Ahmed Saeed Almaqati, Kalthom Komo, Abdullah Alahmadi · 2023 · Cureus
  3. Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study
    Anisha B. Dua, Kerri Ford, Stefano Fiore, Dimitrios A. Pappas, Jud C. Janak, Taylor S. Blachley, Carla Roberts‐Toler, Kelechi Emeanuru, Joel M. Kremer, Alan Kivitz · 2023 · Rheumatology and Therapy
  4. Correlations between ultrafast power Doppler perfusion imaging variables and clinical disease activity in rheumatoid arthritis: potential applications for diagnosing and treating patients in deep clinical remission
    Kuo‐Lung Lai, Pai‐Chi Li · 2024 · ULTRASONOGRAPHY
  5. Measurement of Rheumatoid Arthritis Disease Activity with Rheumatoid Arthritis Disease Activity Index (RADAI) and Comparison with Other Clinical Disease Activity Indexes
    Figen Tuncay, Pınar Borman, Ferda Kaygısız, Hatice Rana Erdem, Emine Eda Kurt · 2015 · Turkiye Klinikleri Journal of Medical Sciences
  6. Association Between Body Composition and Inflammatory Activity in Rheumatoid Arthritis. A Systematic Review
    José Álvarez-Nemegyei, Fátima Annai Buenfil-Rello, Elda Leonor Pacheco-Pantoja · 2016 · Reumatología Clínica (English Edition)
  7. Effect of tumour necrosis factor α blockade on bone metabolism in chronic inflammatory joint diseases
    Francisco Javier Aguilar del Rey, Rosa García-Portales, Manuel Haro Liger, José Rodríguez Andreu, José Luis Casals Sánchez, Rita Pérez González · 2016 · Medicina Clínica (English Edition)
  8. Clinical variables, including novel joint index, associated with future patient‐physician discordance in global assessment of rheumatoid arthritis ( RA ) disease activity based on a large RA database in Japan
    Yusuke Yamamoto, Tetsuji Sawada, Susumu Nishiyama, Koichiro Tahara, Haeru Hayashi, Hiroaki Mori, Eri Kato, Mayu Tago, Toshihiro Matsui, Shigeto Tohma · 2022 · International Journal of Rheumatic Diseases
  9. Evaluation of vascular endothelial growth factor levels in rheumatoid arthritis patients, with and without joint swelling; a comparison with erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor and anti-cyclic citruillnated protein
    Alper Gümüş, Cihan Coşkun, Hümeyra Öztürk Emre, Musa Temel, Berrin Berçık Inal, Hatice Seval, Yasemin Erdoğan Döventaş, Macit Koldaş · 2017 · Turkish Journal of Biochemistry
  10. Von Willebrand Factor and Intima-Media Thickness in Patients With Rheumatoid Arthritis: A Cross-Sectional Study
    Khristina Fedorovych, Roman Yatsyshyn · 2023 · Galician Medical Journal
  11. The impact of depression and anxiety on pain reported by patients with rheumatoid arthritis undergoing treatment
    Nicole Rodrigues de Magalhães, Vitória Novaes Figueiredo Daleaste, Marielle Bernardi Gomes, Márcia Midori Shinzato · 2023 · Acta Scientiarum Health Sciences
  12. Efficacy of Olokizumab against Comorbid Depressive Disorder in Patients with Rheumatoid Arthritis: Preliminary Results of the Study
    Tatyana Andreyevna Lisitsyna, Абрамкин Антон Анатольевич, Dmitry Yu. Veltishchev, O. Seravina, Oksana B. Kovalevskaya, A. B. Borisova, V. G. Ignatiev, Evgeny Lvovich Nasonov · 2024 · Doklady Biochemistry and Biophysics
  13. Efficacy of olokizumab in treating comorbid depression in patients with rheumatoid arthritis: results of a single-center randomized controlled trial
    Tatyana Andreyevna Lisitsyna, Абрамкин Антон Анатольевич, Dmitry Yu. Veltishchev, A. B. Borisova, Evgeny Lvovich Nasonov · 2025 · Rheumatology Science and Practice
  14. Retention of baricitinib-treated patients with rheumatoid arthritis in Japan: Interim results from a prospective observational cohort study
    Yuko Kaneko, Chaochen Wang, Naoto Tsujimoto, Masaru Tanaka, Kei Ikeda · 2025 · Modern Rheumatology
  15. HAND AND FOOT FUNCTION IN LATE-ONSET RHEUMATOID ARTHRITIS: CONFOUNDED BY MULTIPLE FACTORS RATHER THAN SOLELY BY DISEASE ACTIVITY
    Halise Hande Gezer, Mehmet Tuncay Duruöz · 2025 · Anti-Aging Eastern Europe
  16. Dynamics of inflammatory markers and interleukin 6 levels during olokizumab therapy: Results of a single-center randomized controlled trial
    Anastasia Sergeevna Avdeeva, Tatyana Andreyevna Lisitsyna, Абрамкин Антон Анатольевич, Mikhail E. Diatroptov, Evgeny Lvovich Nasonov · 2026 · Rheumatology Science and Practice
  17. Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritis
    Isabell S Nevins, Joy Ardjuna van der Pol, Lotte van Ouwerkerk, G S Helmich, Reinhard Bos, Sjoerd M. van der Kooij, Harald E. Vonkeman, Jessica Bijsterbosch, Pascal Hendrik Pieter de Jong, Melek Güler-Yüksel et al. · 2026 · RMD Open
  18. Skeletal effects of JAK1/2 inhibition versus IL-6 receptor blockade in rheumatoid arthritis: a post hoc comparative cohort analysis based on two prospective observational studies
    Nils Schulz, Pascal van Wijnen, Tim Wilhelmi, Ulf Müller‐Ladner, Uwe Lange, Philipp Klemm · 2026 · Frontiers in Pharmacology
  19. The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis
    Yael Luck, Murray G Baron, Sonia Bardakjian, Laeora Berkson, Maura Buchignani, Sabrina Fallavollita, Frédérique Giac, Geneviève Gyger, Solène Tatibouet, Marie Hudson · 2014 · Clinical Rheumatology
  20. Toxoplasma gondii Infection Delays the Onset and Decreases the Severity of Rheumatoid Arthritis in a Programmed Death-1 Mediated Mechanism
    Shaimaa Ahmed Sharaf El Deen, Reham Mustafa Brakat, Reem Mohsen Elkholy, Dalia Salah, Shaimaa Soliman · 2019 · International Journal of Current Microbiology and Applied Sciences
  21. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs
    Marcos Cruces, Soham Al Snih, Natalí Serra-Bonett, Juan C. Rivas · 2019 · Reumatología Clínica (English Edition)
  22. A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA
    Christopher F. Bell, Shirley P. Huang, Louise Yu, Maral DerSarkissian, Guillaume Germain, Andrew L. Concoff, Carlyne M. Averell, Bernard Rubin, Yuqian M. Gu, Mei Sheng Duh et al. · 2022 · Rheumatology and Therapy
  23. The diagnostic laboratory tests in rheumatic diseases
    Rossella Talotta · 2023 · Elsevier eBooks
  24. In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement
    Chiara Pellicano, Amalia Colalillo, Valeria Carnazzo, Serena Redi, Valerio Basile, Mariapaola Marino, Umberto Basile, Edoardo Rosato · 2023 · Journal of Personalized Medicine
  25. Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial
    Panagiotis Athanassiou, Pelagia Katsimbri, Andreas Bounas, Sοusana Gazi, T. Sarikoudis, Victoria Syrigou, Dimitrios T. Boumpas, EMBRACE Study Group, Athanasios N. Georgiadis, Ioannis Kallitsakis et al. · 2024 · Clinical Rheumatology
  26. PULMONARY FUNCTION IN RHEUMATOID ARTHRITS: A CROSS-SECTIONAL STUDY
    Aishwarya Malode, R N YADAV, Girdhar Gopal Goyal, Gunja Jain, AJAY MATHUR, Laxmikant Goyal · 2024 · International Journal of Current Pharmaceutical Research
  27. Selbst-Monitoring bei entzündlich-rheumatischen Erkrankungen
    Christina Kampling, Gamal Chehab, M. Schneider, Jutta Richter · 2014 · Zeitschrift für Rheumatologie
  28. A Quality Improvement Approach to Rheumatoid Arthritis Management With Biologic Disease-Modifying Antirheumatic Drugs: Assessing Variability in a Treatment Pathway
    Amish J. Dave, Heather O. Tory, J. Adebukola Awosogba, Jonathan S. Coblyn, Bonnie Lee Bermas, Daniel H. Solomon, Sonali Parekh Desai · 2016 · JCR Journal of Clinical Rheumatology
  29. 5-HT2A a serotonin receptor with a possible role in joint diseases
    Anders Kling · 2013 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  30. 8. Recent Advance in Diagnosis and Treatment of Rheumatoid Arthritis
    Yasuo Suzuki · 2015 · Nihon Naika Gakkai Zasshi
  31. Development and validation of a composite endpoint as a quality indicator in elderly care
    C.S. Hofman · 2016 · Radboud Repository (Radboud University)
  32. Exploring the impact of fatigue on work ability of people with rheumatic disease
    Deirdre Connolly · 2016 · Arrow@dit (Dublin Institute of Technology)
  33. Efficiency of tight monitoring by nurse practitioners in rheumatoid arthritis patients in remission after treatment with rituximab: study protocol for a randomized, open-label, controlled trial
    Deborah Lebedieff, Hélène Boulard, Béatrice Godon, Marine Grandjean, Christian Marcelli, Olivier Vittecoq · 2018 · Clinical Trials in Orthopedic Disorders
  34. Healthcare Utilization in Rheumatic Diseases
    Nina Mars · 2019 · Työväentutkimus Vuosikirja
  35. The Role of Soluble Subtype of the Receptor for Advanced Glycation End Product (sRAGE) in Rheumatoid Arthrirtis Disease Activity and Treatment Follow-up
    M.D. NEHAL EL-FAWY MAHMOUD DOAA EL-ZOGHBY, M.D. SAFAA M. EL-RAHMAN NERMIN H. EL-GHARBAWY · 2019 · The Medical Journal of Cairo University/The Medical Journal of Cairo University
  36. Outcome Measures in Rheumatoid Arthritis
    Yusuf Yazıcı, Hilal Maradit Kremers · 2014 · Springer eBooks
  37. Estudo do acometimento articular na síndrome de Sjögren primária pelo ultrassom de alta resolução de mãos e punhos
    Lissiane Karine Noronha Guedes · 2020
  38. Clinical and Laboratory Assessments
    Ian C. Scott, James Benjamin Galloway, David Lloyd Scott · 2015 · Springer eBooks
  39. Influence du sexe sur les caractéristiques cliniques et leur évolution dans une cohorte de 5376 patients atteints de polyarthrite rhumatoïde
    Seung-Hwan Shin, Eun Hye Park, Eun Ha Kang, Yun Jong Lee, Yeong Wook Song, You‐Jung Ha · 2022 · Revue du Rhumatisme
  40. An Observational Study on Assessment of Disease Activity in Rheumatoid Arthritis Patients Using Patient-Based Disease Activity Score 2 (PDAS-2)
    Harpreet Singh, Somdatta Giri, Hemant Kumar, Pratibha Yonzone, Mahima Khatkar · 2021 · SN Comprehensive Clinical Medicine
  41. PBMC miRNA in diagnosis of rheumatoid arthritis
    Nishtha Agarwal, Sanjeev Kapoor, Shri Ram Garg, A N Malaviya, Shweta Dubey, Puja Nagpal · 2022 · International Journal of Health Sciences
  42. Dose Reduction of Biological Therapies in Patients with Inflammatory Arthritis: Maintaining Stable Disease Activity on Reduced Dose
    Line Uhrenholt · 2022
  43. Prevalence of remission in patients with rheumatoid arthritis in daily clinical practice: long-term data from a tertiary care centre
    N. Gildemeister, Imke Redeker, Bjoern Buehring, Ioana Andreica, DAVID M. KIEFER, Xenofon Baraliakos, Jürgen Braun, Uta Kiltz · 2023 · Clinical and Experimental Rheumatology
  44. Rheumatoid Arthritis Disease Activity Influenced by Acupuncture
    Diana Seixas · 2024 · American Journal of Biomedical Science & Research
  45. Psychometric properties of the Turkish version of the short form Valued Life Activities Disability Questionnaire in patients with rheumatoid arthritis
    Ayşen Canan Pakeloğlu, Meltem Koç, Emine Figen Tarhan, Banu Bayar, Kılıçhan Bayar · 2025 · Work
  46. Challenging the One-Size-Fits-All Approach in Rheumatoid Arthritis Management by Addressing Serostatus-Driven Differences
    Andrei-Flavius Radu, Andrei-Flavius Radu, Carmen Delia Nistor-Cseppento, Delia Mirela Ţiţ, Lavinia Cristina Moleriu, Nicoleta Anamaria Paşcalău, Radu Dumitru Moleriu, SIMONA GABRIELA BUNGAU · 2025 · Balneo and PRM Research Journal
  47. Efficacy and Safety of the Bushen Quhan Zhiwang Decoction to Achieve Clinical Deep Remission in Rheumatoid Arthritis: Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial
    Longxiao Liu, Jinping Wang, Yanyu Chen, Yunlong Fang, Zihan Wang, Xiaojing Liu, Lidong Hong, Qingwen Tao, Yuan Xu · 2025 · Journal of Pain Research
  48. Additional file 2 of Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial
    Martin Jan Bergman, Namita L. Tundia, Martin, Naomi, Jessica L. Suboticki, Patel, Jayeshkumar, Debbie Goldschmidt, Song, Yan, Wright, Grace C. · 2022 · Figshare
  49. Additional file 1 of Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial
    Martin Jan Bergman, Namita L. Tundia, Martin, Naomi, Jessica L. Suboticki, Patel, Jayeshkumar, Debbie Goldschmidt, Song, Yan, Wright, Grace C. · 2022 · Figshare
  50. Assessing the impact of an integrated health-system specialty pharmacy model on clinical disease activity index scores in patients with rheumatoid arthritis
    Thuyvan Phan, Pooja Datt, Liang Zhao, Michael Tilkens, Debbie Liang · 2025 · American Journal of Health-System Pharmacy
  51. Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)
    Georg Pongratz, Rieke Alten, Torsten Witte, Christine Pausch, Robert Reinhold, David Pittrow, Gerd Rüdiger Burmester · 2026 · Rheumatology and Therapy
  52. Are global definitions enough? Revisiting CDAI and SDAI remission cut-offs in Brazilian Rheumatoid Arthritis patients
    Lucas Castro Pires, Alisson Pugliesi, Cleandro Pires de Albuquerque, Vítor Alves Cruz, Manoel Barros Bértolo, Ana Paula Monteiro Gomides, Rina Dalva Neubarth Giorgi, Letícia Rocha Pereira, S. Radominski, Ivânio Alves Pereira et al. · 2026 · Revista Brasileira de Reumatologia
  53. Patient-reported outcomes in patients with rheumatoid arthritis treated with baricitinib: A prospective observational study in Japan
    Yuko Kaneko, Naoto Tsujimoto, Izumi Sato, Taisuke Kojima, K. Ikeda · 2026 · Modern Rheumatology
  54. Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial
    Tatyana Andreyevna Lisitsyna, Абрамкин Антон Анатольевич, Dmitry Yu. Veltishchev, A. B. Borisova, Evgeny Lvovich Nasonov · 2026 · Doklady Biochemistry and Biophysics
  55. Elaboration et évaluation d’un programme d’exercice aérobie sur cycloergomètre et de sa récupération immergée chez le patient atteint de polyarthrite rhumatoïde.
    Daniele Peres · 2018 · theses.fr (ABES)
  56. Coping with an Uncertain or Poor Cancer Prognosis as an Adolescent or Young Adult: A Cross-Sectional Cluster Analysis
    Milou J. P. Reuvers, Winette T.A. van der Graaf, Olga Husson, Leyla Azarang · 2026 · Current Oncology
  57. The shared burden of frailty in rheumatoid arthritis – a qualitative study of informal caregiving roles and support needs from the perspectives of patients and their informal caregivers
    Signe Marie Abild, Julie Midtgaard, Charlotte Werdal Hansen, Luise Holberg Lindgren, Katrine Storm Piper, Bente Glintborg, Tanja Thomsen, Mathilde Glud Christensen, Bente Appel Esbensen · 2026 · BMC Rheumatology
  58. Qushi Juanbi Granules Combined with Shenling Baizhu Powder in Rheumatoid Arthritis Patients with Low Disease Activity and Pi Deficiency and Dampness Pattern: A Randomized, Double-Blind, Controlled Trial
    Yi-hong Yang, Kaixin Gao, You-bang Liang, Yu Wen, YU Yi-hang, Sheng-qin Yang, Chuanjian Lu, Maojie Wang, Xiu-min Chen, Runyue Huang · 2026 · Chinese Journal of Integrative Medicine
  59. Validation of the Brief-Cope Questionnaire in a Seropositive Rheumatoid Arthritis Population
    Ioana Iliadis, Ivo Heitland, Kirsten Hoeper, Torsten Witte, Kai G. Kahl, Britta Stapel, Dirk Meyer‐Olson · 2026 · medRxiv
  60. Human T-cell leukaemia virus type 1-associated myelopathy in patients with rheumatoid arthritis: A case series highlighting functional disability and diagnostic challenges
    Masayuki Murai, Kunihiko Umekita, Risa Kudo, Masatoshi Kimura, Chihiro Iwao, Kosho Iwao, Takeshi Kawaguchi, Motohiro Matsuda, Shunichi Miyauchi, Yayoi Hashiba et al. · 2026 · Modern Rheumatology